Inflammation, NF-κB, and Chronic Diseases: How are They Linked?

被引:165
|
作者
Kunnumakkara, Ajaikumar B. [1 ]
Shabnam, Bano [1 ]
Girisa, Sosmitha [1 ]
Harsha, Choudhary [1 ]
Banik, Kishore [1 ]
Devi, Th Babita [1 ]
Choudhury, Ruplekha [1 ]
Sahu, Henamayee [1 ]
Parama, Dey [1 ]
Sailo, Bethsebie L. [1 ]
Thakur, Krishan Kumar [1 ]
Gupta, Subash C. [2 ]
Aggarwal, Bharat B. [3 ]
机构
[1] Indian Inst Technol Guwahati, Canc Biol Lab, DAILAB, Dept Biosci & Bioengn, Gauhati 781039, Assam, India
[2] Banaras Hindu Univ, Inst Sci, Dept Biochem, Varanasi, Uttar Pradesh, India
[3] Inflammat Res Ctr, 1221 van Nuys St, San Diego, CA 92109 USA
关键词
ccytokines; inflammation; NF-kappa B; signal transduction; therapies; TUMOR-NECROSIS-FACTOR; HEMATOPOIETIC STEM-CELLS; ALPHA KINASE ACTIVATION; BREAST-CANCER CELLS; ANTIAPOPTOTIC GENE-PRODUCTS; FACTOR-INDUCED APOPTOSIS; MAPK SIGNALING PATHWAYS; HUMAN COLORECTAL-CANCER; HUMAN ENDOTHELIAL-CELLS; B16F-10; MELANOMA-CELLS;
D O I
10.1615/CritRevImmunol.2020033210
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Most chronic diseases, caused by lifestyle factors, appear to be linked to inflammation. Inflammation is activated mechanistically, and nuclear factor-kappa B (NF-kappa B) is a significant mediator. NF-kappa B, one of the most studied transcription factors, was first identified in the nucleus of B lymphocytes almost three decades ago. This protein has a key function in regulating the human immune system, and its dysregulation has been linked to many chronic diseases including asthma, cancer, diabetes, rheumatoid arthritis, inflammation, and neurological disorders. Physiologically, many cytokines have been discovered that activate NF-kappa B. Pathologically, environmental carcinogens such as cigarette smoke, radiation, bacteria, and viruses can also activate this transcription factor. NF-kappa B activation controls expression of more than 500 genes, and most are deleterious to the human body when dysregulated. More than 70,000 articles have been published regarding NF-kappa B. This review emphasizes the upside and downside of NF-kappa B in normal and disease conditions and the ways in which we can control this critical transcription factor in patients.
引用
收藏
页码:1 / 39
页数:39
相关论文
共 50 条
  • [41] The complexity of NF-κB signaling in inflammation and cancer
    Bastian Hoesel
    Johannes A Schmid
    Molecular Cancer, 12
  • [42] Inflammation meets cancer, with NF-κB as the matchmaker
    Ben-Neriah, Yinon
    Karin, Michael
    NATURE IMMUNOLOGY, 2011, 12 (08) : 715 - 723
  • [43] NF-?B: a mediator that promotes or inhibits angiogenesis in human diseases?
    Jiang, Yijing
    Zhang, Jie
    Shi, Conglin
    Li, Xingjuan
    Jiang, Yongying
    Mao, Renfang
    EXPERT REVIEWS IN MOLECULAR MEDICINE, 2023, 25
  • [44] NF-κB-related genetic diseases
    Courtois, G
    Smahi, A
    CELL DEATH AND DIFFERENTIATION, 2006, 13 (05) : 843 - 851
  • [45] Chronic inflammation in biomaterial-induced periprosthetic osteolysis: NF-κB as a therapeutic target
    Lin, Tzu-hua
    Tamaki, Yasunobu
    Pajarinen, Jukka
    Waters, Heather A.
    Woo, Deanna K.
    Yao, Zhenyu
    Goodman, Stuart B.
    ACTA BIOMATERIALIA, 2014, 10 (01) : 1 - 10
  • [46] NF-κB as a therapeutic target in neurodegenerative diseases
    Camandola, Simonetta
    Mattson, Mark P.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (02) : 123 - 132
  • [47] Tuning up inflammation:: How DNA sequence and chromatin organization control the induction of inflammatory genes by NF-κB
    Natoli, G
    FEBS LETTERS, 2006, 580 (12) : 2843 - 2849
  • [48] Obstructive sleep apnea, cardiovascular disease, and inflammation -: is NF-κB the key?
    Williams, Antoinette
    Scharf, Steven M.
    SLEEP AND BREATHING, 2007, 11 (02) : 69 - 76
  • [49] Pioglitazone reduces inflammation through inhibition of NF-κB in polymicrobial sepsis
    Kaplan, Jennifer
    Nowell, Marchele
    Chima, Ranjit
    Zingarelli, Basilia
    INNATE IMMUNITY, 2014, 20 (05) : 519 - 528
  • [50] The role of chalcones in suppression of NF-κB-mediated inflammation and cancer
    Yadav, Vivek R.
    Prasad, Sahdeo
    Sung, Bokyung
    Aggarwal, Bharat B.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2011, 11 (03) : 295 - 309